By Karen Roman
ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately.
“His proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth and leadership in rare and inflammatory diseases,” said Kenji Cunnion, M.D., MPH, ReAlta’s co-founder, Chief Medical Officer and Board Member.
Dr. Berman has over 20 years of experience in the biopharmaceutical industry in leadership positions including public market execution in fields like immunology and neuroscience, the company stated.
He founded and previously served as Chief Executive Officer of Coya Therapeutics, Inc. (Nasdaq: COYA), and he is also part of the board of directors of Atea Pharmaceuticals, Inc. (Nasdaq: AVIR), it said.
READ MORE
NYSE Firesides Scheduled Dec 9, 2025 & Feb 3, 2026
Never Miss our Weekly Highlights HERE
Contact:
Exec Edge
Editor@executives-edge.com
Click HERE to follow us on LinkedIn
